Clinical Trial Update: Gemcitabine With Oxaliplatin (GEMOX) in Patients With Advanced Hepatocellular Carcinoma After Failure of Sorafenib Treatment [Phase 2]

View source ↗

Summary

A phase 2 trial evaluating gemcitabine with oxaliplatin (GEMOX) in patients with advanced unresectable hepatocellular carcinoma after sorafenib failure has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Gemcitabine with oxaliplatin (GEMOX)

Snippet

Sponsor: Yonsei University | Conditions: Hepatocellular Carcinoma, Unresectable, Advanced | Phase 2 | Status: COMPLETED